- Home
- AMC vs HROW Comparison
AMC vs HROW Comparison
Compare AMC & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMC
- HROW
- Stock Information
- Founded
- AMC 1920
- HROW 1998
- Country
- AMC United States
- HROW United States
- Employees
- AMC N/A
- HROW N/A
- Industry
- AMC Movies/Entertainment
- HROW Biotechnology: Pharmaceutical Preparations
- Sector
- AMC Consumer Discretionary
- HROW Health Care
- Exchange
- AMC Nasdaq
- HROW Nasdaq
- Market Cap
- AMC 1.3B
- HROW 1.4B
- IPO Year
- AMC 2013
- HROW N/A
- Fundamental
- Price
- AMC $2.59
- HROW $35.99
- Analyst Decision
- AMC Hold
- HROW Strong Buy
- Analyst Count
- AMC 7
- HROW 7
- Target Price
- AMC $3.94
- HROW $68.50
- AVG Volume (30 Days)
- AMC 27.6M
- HROW 706.3K
- Earning Date
- AMC 11-05-2025
- HROW 11-10-2025
- Dividend Yield
- AMC N/A
- HROW N/A
- EPS Growth
- AMC N/A
- HROW N/A
- EPS
- AMC N/A
- HROW N/A
- Revenue
- AMC $4,915,600,000.00
- HROW $227,661,000.00
- Revenue This Year
- AMC $8.13
- HROW $43.92
- Revenue Next Year
- AMC $6.66
- HROW $41.22
- P/E Ratio
- AMC N/A
- HROW N/A
- Revenue Growth
- AMC 9.42
- HROW 47.69
- 52 Week Low
- AMC $2.45
- HROW $20.85
- 52 Week High
- AMC $5.56
- HROW $54.19
- Technical
- Relative Strength Index (RSI)
- AMC 37.83
- HROW 37.11
- Support Level
- AMC $2.49
- HROW $36.20
- Resistance Level
- AMC $2.92
- HROW $38.52
- Average True Range (ATR)
- AMC 0.12
- HROW 1.87
- MACD
- AMC -0.02
- HROW -0.33
- Stochastic Oscillator
- AMC 20.21
- HROW 2.84
About AMC AMC Entertainment Holdings Inc.
AMC Entertainment Holdings Inc is involved in the theatrical exhibition business. It owns, operates, or has interests in theatres located in the United States and Europe. It provides amenities such as plush, power recliners, MacGuffins full bars, AMC Dine-In Theatres, and premium presentation. The company has identified two reportable segments and reporting units for its theatrical exhibition operations, U.S. markets and International markets. It derives key revenue from the U.S.
About HROW Harrow Inc.
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.